CVE-2024-32822: Implecode Reviews Plus
Medium severity, CVSS 4.3. EPSS: 0.3% chance of exploitation in the next 30 days.
Missing Authorization vulnerability in impleCode Reviews Plus.This issue affects Reviews Plus: from n/a through 1.3.4.
Affected products
Published 2024-04-26. Last modified 2026-06-17.